This case-control study aimed to preliminarily investigate the genetic connection between the IL12A gene and CAD to provide a potentially novel target and a theoretical foundation for anti-inflammatory therapy in CAD (Figure 1). The gene discussed is IL12A; the disease is coronary artery disorder.